CDC Seeks Public Input on National Tuberculosis Laboratory Services Survey to Enhance Diagnostic Capabilities

The Centers for Disease Control and Prevention (CDC) announced a crucial new initiative on October 27, 2026, seeking public input on a proposed National Tuberculosis (TB) Laboratory Services Survey. Published in the Federal Register, this notice outlines the CDC's plan to conduct a comprehensive assessment of mycobacteriology diagnostic capabilities across U.S. laboratories. The survey aims to gather up-to-date information on the capacity, capabilities, and accessibility of these vital services, directly impacting the nation's public health response to tuberculosis.

Background of the Initiative

Tuberculosis, a serious infectious disease, continues to pose a significant public health challenge both globally and within the United States. Accurate and timely laboratory diagnosis is paramount for effective treatment and control measures, preventing further transmission. The CDC, as the nation's leading public health agency, plays a central role in monitoring disease trends, developing prevention strategies, and supporting diagnostic infrastructure. This proposed survey represents a renewed effort to understand the current landscape of TB diagnostic services, building upon previous assessments to identify how the system has evolved and where improvements are most needed. The initiative operates within the framework of the Paperwork Reduction Act of 1995 (PRA), which mandates federal agencies to seek public and OMB approval before collecting information from the public. This process ensures that data collection is necessary, practical, and minimally burdensome.

Scope and Methodology of the Survey

The National Tuberculosis Laboratory Services Survey is designed as an electronic questionnaire, developed in collaboration with the Association of Public Health Laboratories (APHL). This partnership leverages APHL's expertise and reach within the laboratory community. The survey will be distributed via email, targeting a broad spectrum of up to 1,000 laboratories, including clinical, commercial, federal, academic medical, and public health facilities. The data collection will encompass a wide array of information related to TB diagnostics, including specific laboratory services offered, testing methods employed, testing volumes, types of specimens handled, practices for referral and reference testing, specimen handling and transport protocols, reporting practices, identified training needs, and current proficiency testing and quality assurance measures. The explicit goal is to identify existing gaps that may impede the timely and accurate diagnosis of TB cases across the country.

Data Handling and Agency Involvement

APHL will be responsible for the initial collection and analysis of the survey responses. A commitment to data security is stated, with respondent data electronically stored on APHL servers. While raw data may be shared with the CDC, specific identifying information pertaining to individuals will be removed by APHL prior to any data transfer to the CDC. The CDC's engagement in the project will involve consulting on the analysis and interpretation of the findings. Aggregate summaries of the survey results will also be provided to the CDC after APHL completes its analysis. This division of labor underscores a collaborative approach, combining APHL's operational expertise with CDC's public health oversight.

Public Comment Opportunity and Burden Assessment

In adherence to the Paperwork Reduction Act, the CDC is inviting public and federal agency comments on this proposed information collection. The commenting period extends until December 28, 2026. Interested parties can submit their feedback through the Federal eRulemaking Portal at www.regulations.gov or via U.S. mail to the specified CDC address. The PRA process specifically solicits input on several critical aspects: the necessity and practical utility of the information, the accuracy of the estimated burden on respondents, potential enhancements to data quality and clarity, and methods to minimize respondent burden, including the use of electronic tools. The CDC estimates a total annual burden of 417 hours for this project, with each of the 1,000 participating laboratories expected to spend approximately 25 minutes (25/60 hours) completing the online survey. Importantly, respondents will not receive federal funds for their participation, nor are there any additional costs beyond their time commitment.

Implications for Public Health

The insights gained from this national survey hold significant implications for the future of tuberculosis control in the United States. By pinpointing areas where laboratory capacity or capabilities are lacking, the CDC and its partners can develop targeted interventions, resource allocations, and training programs. This could lead to more standardized and efficient diagnostic pathways, reduced delays in identifying infected individuals, and ultimately, a more robust public health defense against TB. Understanding the current state of mycobacteriology services is crucial for adapting to emerging challenges, such as drug-resistant strains of TB, and for ensuring equitable access to high-quality diagnostic testing nationwide. The findings will serve as a foundational element for future policy decisions and strategic planning within the realm of infectious disease surveillance and control.